GlassScriptPhysician profile
Brittany Stern
NPI 1538777594
$3,053.34
in general payments reported to CMS, 2019-2025
15 companies · $625 in 2025
The $625 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $903 · 2022: $590 · 2023: $499 · 2024: $436 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $691.57 | 2024-2025 | Daxxify |
| Astrazeneca Pharmaceuticals LP | $592.49 | 2021-2023 | Tagrisso |
| Sobi, INC | $384.20 | 2022-2023 | |
| Pharmacyclics LLC, An Abbvie Company | $261.90 | 2021-2023 | Epkinly, Imbruvica |
| Dova Pharmaceuticals | $246.23 | 2021 | |
| Amgen INC. | $200.95 | 2021-2023 | Lumakras, Vectibix, Xgeva |
| Genzyme Corporation | $180.44 | 2021-2024 | |
| Pharmaessentia USA Corporation | $136.86 | 2023-2025 | Besremi |
| Abbvie INC. | $135.74 | 2024-2025 | |
| Genentech USA, INC. | $67.42 | 2021-2024 | Venclexta |
| Janssen Biotech, INC. | $58.05 | 2021-2022 | |
| Glaxosmithkline, LLC. | $28.61 | 2025 | Ojjaara, Blenrep |
| Novartis Pharmaceuticals Corporation | $26.17 | 2021 | |
| Cti Biopharma Corp. | $23.55 | 2023 | Vonjo |
| Sirtex Medical INC | $19.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.